The development of three-dimensional environments to mimic the in vivo cellular response is a problem in the building of disease models. This study aimed to synthesize and validate three-dimensional support for culturing monoclonal plasma cells (mPCs) as a disease model for multiple myeloma. The three-dimensional environment is a biomimetic microgel formed by alginate microspheres and produced on a microfluidic device whose surface has been functionalized by a layer-by-layer process with components of the bone marrow’s extracellular matrix, which will interact with mPC. As a proof of concept, RPMI 8226 cell line cells were cultured in our 3D culture platform. We proved that hyaluronic acid significantly increased cell proliferation and corroborated its role in inducing resistance to dexamethasone. Despite collagen type I having no effect on proliferation, it generated significant resistance to dexamethasone. Additionally, it was evidenced that both biomolecules were unable to induce resistance to bortezomib. These results validate the functionalized microgels as a 3D culture system that emulates the interaction between tumoral cells and the bone marrow extracellular matrix. This 3D environment could be a valuable culture system to test antitumoral drugs efficiency in multiple myeloma.
Multiple myeloma is a hematologic neoplasm caused by an uncontrolled clonal proliferation of neoplastic plasma cells (nPCs) in the bone marrow. The development and survival of this disease is tightly related to the bone marrow environment. Proliferation and viability of nPCs depend on their interaction with the stromal cells and the extracellular matrix components, which also influences the appearance of drug resistance. Recapitulating these interactions in an in vitro culture requires 3D environments that incorporate the biomolecules of interest. In this work, we studied the proliferation and viability of three multiple myeloma cell lines in a microgel consisting of biostable microspheres with fibronectin (FN) on their surfaces. We also showed that the interaction of the RPMI8226 cell line with FN induced cell arrest in the G0/G1 cell cycle phase. RPMI8226 cells developed a significant resistance to dexamethasone, which was reduced when they were treated with dexamethasone and bortezomib in combination.
Bone marrow mechanical conditions play a key role in multiple myeloma cancer. The complex mechanical and chemical conditions, as well as the interactions with other resident cells, hinder the development of effective treatments. Agent-based computational models, capable of defining the specific conditions for every single cell, can be a useful tool to identify the specific tumor microenvironment. In this sense, we have developed a novel hybrid 3D agent-based model with coupled fluid and particle dynamics to study multiple myeloma cells’ growth. The model, which considers cell–cell interactions, cell maturation, and cell proliferation, has been implemented by employing user-defined functions in the commercial software Fluent. To validate and calibrate the model, cell sedimentation velocity and cell proliferation rates have been compared with in vitro results, as well as with another previously in-house developed model. The results show that cell proliferation increased as cell–cell, and cell–extracellular matrix interactions increased, as a result of the reduction n maturation time. Cells in contact form cell aggregates, increasing cell–cell interactions and thus cell proliferation. Saturation in cell proliferation was observed when cell aggregates increased in size and the lack of space inhibited internal cells’ proliferation. Compared with the previous model, a huge reduction in computational costs was obtained, allowing for an increase in the number of simulated cells.
Photodynamic therapy (PDT) offers localized, controllable cancer treatment through reactive oxygen species (ROS) generated by light-activated photosensitizers. Three-dimensional (3D) printing of PDT-active materials has emerged as a powerful tool for fabricating customized structures with controlled architecture and composition. However, conventional PDT materials often require complex, multi-step syntheses with low yields. Consequently, integrating natural photosensitizers into biocompatible matrices represents a crucial step towards sustainable PDT. Here, microalgae-derived materials are investigated to fabricate high-resolution scaffolds via 3D laser printing while retaining the intrinsic photoactive properties of chlorophyll. Within these matrices, native chlorophyll derivatives fulfill a triple light-induced function: driving microalgal lipid biosynthesis, initiating additive-free 3D laser printing, and acting as immobilized photosensitizers. Fluorometric assays confirm robust ROS generation upon red-light irradiation of the 3D printed microalgae-derived material. The photodynamic efficacy of these scaffolds is evaluated in melanoma cells to demonstrate their therapeutic potential. In vitro studies reveal significantly reduced cell viability upon irradiation, while maintaining cytocompatibility under dark conditions. Furthermore, the microalgae-derived materials enable the fabrication of scaffolds with varied complex geometries and feature sizes while retaining photodynamic activity. These findings demonstrate a highly versatile, biobased strategy combining natural photosensitizers with 3D laser printing to produce functional platforms for precision PDT.